Mark D. TrailSmith

529 total citations
8 papers, 454 citations indexed

About

Mark D. TrailSmith is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Mark D. TrailSmith has authored 8 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Genetics. Recurrent topics in Mark D. TrailSmith's work include Virus-based gene therapy research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Click Chemistry and Applications (1 paper). Mark D. TrailSmith is often cited by papers focused on Virus-based gene therapy research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Click Chemistry and Applications (1 paper). Mark D. TrailSmith collaborates with scholars based in United States, Germany and Switzerland. Mark D. TrailSmith's co-authors include Robert S. Mittler, Kerry Klussman, Michael K. Hoffmann, Peter V.N. Bodine, Barry S. Komm, R. Bruce Rutherford, Marc Charette, Maria Ryan, David Bermudes and David Willner and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Medicinal Chemistry and Journal of Bone and Mineral Research.

In The Last Decade

Mark D. TrailSmith

8 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark D. TrailSmith United States	7	153	141	117	67	60	8	454
Sylvie Mathieu France	13	117 0.8×	350 2.5×	80 0.7×	72 1.1×	82 1.4×	24	731
Lu Qiao China	12	196 1.3×	315 2.2×	106 0.9×	54 0.8×	39 0.7×	27	624
Juan Luis Callejas‐Valera United States	12	121 0.8×	299 2.1×	225 1.9×	27 0.4×	36 0.6×	19	693
Loredana Cavicchini Italy	13	56 0.4×	286 2.0×	187 1.6×	88 1.3×	35 0.6×	27	634
Francesca Ferrera Italy	15	309 2.0×	141 1.0×	102 0.9×	23 0.3×	39 0.7×	30	559
Stephan Kontos Switzerland	13	253 1.7×	307 2.2×	94 0.8×	198 3.0×	70 1.2×	14	788
Laura Blanco Spain	13	90 0.6×	270 1.9×	124 1.1×	24 0.4×	62 1.0×	21	496
Alexander C. James Australia	10	62 0.4×	302 2.1×	101 0.9×	86 1.3×	51 0.8×	15	531
Paul D. Robbins United States	8	164 1.1×	376 2.7×	94 0.8×	46 0.7×	302 5.0×	8	703

Countries citing papers authored by Mark D. TrailSmith

Since Specialization

Citations

This map shows the geographic impact of Mark D. TrailSmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. TrailSmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. TrailSmith more than expected).

Fields of papers citing papers by Mark D. TrailSmith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. TrailSmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. TrailSmith. The network helps show where Mark D. TrailSmith may publish in the future.

Co-authorship network of co-authors of Mark D. TrailSmith

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. TrailSmith. A scholar is included among the top collaborators of Mark D. TrailSmith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. TrailSmith. Mark D. TrailSmith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Gilbert, A., S Caltabiano, Frank E. Koehn, et al.. (2002). Pyrazolopyrimidine-2,4-dione Sulfonamides: Novel and Selective Calcitonin Inducers. Journal of Medicinal Chemistry. 45(11). 2342–2345. 24 indexed citations

Luo, Xiaobo, Ming Feng, Trung Bao Le, et al.. (2001). Tumor Amplified Protein Expression Therapy: Salmonella as a Tumor-Selective Protein Delivery Vector. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 12(3). 127–135. 59 indexed citations

Gilbert, A., S Caltabiano, Denise Roberts, et al.. (2000). Novel and Selective Calcitonin-Inducing Agents. Journal of Medicinal Chemistry. 43(6). 1223–1233. 5 indexed citations

Mittler, Robert S., et al.. (1999). Anti–4-1bb Monoclonal Antibodies Abrogate T Cell–Dependent Humoral Immune Responses in Vivo through the Induction of Helper T Cell Anergy. The Journal of Experimental Medicine. 190(10). 1535–1540. 152 indexed citations

Trail, Pamela A., David Willner, A. Bianchi, et al.. (1999). Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin.. PubMed. 5(11). 3632–8. 32 indexed citations

Trail, Pamela A., David Willner, Jay O. Knipe, et al.. (1997). Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.. PubMed. 57(1). 100–5. 45 indexed citations

Bodine, Peter V.N., Mark D. TrailSmith, & Barry S. Komm. (1996). Development and characterization of a conditionally transformed adult human osteoblastic cell line. Journal of Bone and Mineral Research. 11(6). 806–819. 81 indexed citations

Rutherford, R. Bruce, Mark D. TrailSmith, Maria Ryan, & Marc Charette. (1992). Synergistic effects of dexamethasone on platelet-derived growth factor mitogenesis in vitro. Archives of Oral Biology. 37(2). 139–145. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact